Inventor · disambiguated record
Minhua Chen
Also filed as: CHEN MINHUA
60 granted patents·25 pending applications·49 citations·filing 2010–2025
97Inventor score
Files withCRYSTAL PHARMACEUTICAL SUZHOU CO LTD34CRYSTAL PHARMATECH CO LTD23RECEPTOS LLC6CHEN MINHUA5SHANGHAI NK CELL TECH CO LTD4
Top patents by PatentIndex Score
85 records- 0191US10246418B2Crystal form of lenvatinib methanesulfonate salt and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Apr 2, 2019·6 cites·9 claims
- 0290US11827630B2Crystal form of lanifibranor, preparation method therefor, and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2022·Granted Nov 28, 2023·1 cites·6 claims
- 0389US11117871B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2020·Granted Sep 14, 2021·2 cites·16 claims
- 0485US10577334B2Crystalline form E of tafamidis meglumine, process for preparation and use thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Mar 3, 2020·2 cites·9 claims
- 0584US10882830B2Crystal form of ozanimod hydrochloride and processes for preparation thereforRECEPTOS LLC·Filed 2017·Granted Jan 5, 2021·2 cites·12 claims
- 0684US10703724B2Crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and processes for preparation thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Jul 7, 2020·3 cites·20 claims
- 0784US9994579B2Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of saltCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted Jun 12, 2018·3 cites·10 claims
- 0882US11795152B2Crystal form of tafamidis and preparation method therefor and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2021·Granted Oct 24, 2023·1 cites·19 claims
- 0981US11066384B2Crystalline forms of ARN-509, preparation method and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2020·Granted Jul 20, 2021·1 cites·18 claims
- 1080US10759779B2Crystalline form of orexin receptor antagonist, processes for preparation thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2020·Granted Sep 1, 2020·1 cites·8 claims
- 1179US9751889B2Crystalline form I of ibrutinibCRYSTAL PHARMATECH INC·Filed 2014·Granted Sep 5, 2017·6 cites·19 claims
- 1277US11117876B2Crystalline form of ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2018·Granted Sep 14, 2021·2 cites·9 claims
- 1377US11111223B2Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2017·Granted Sep 7, 2021·1 cites·36 claims
- 1476US10752595B2Crystalline forms of a bromodomain and extraterminal protein inhibitor drug, processes for preparation thereof, and use thereofCRYSTAL PHARMACEUTICAL (SUZHOU) CO LTD·Filed 2017·Granted Aug 25, 2020·1 cites·22 claims
- 1575US11339158B2Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2018·Granted May 24, 2022·1 cites·7 claims
- 1675US10604528B2Galunisertib crystalline form, preparation method thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Mar 31, 2020·1 cites·4 claims
- 1775US2023271927A1Crystalline forms of gsk1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2023·Application pending·0 cites
- 1874US11028060B2Crystalline forms of ozanimod and processes for preparation thereofRECEPTOS LLC·Filed 2017·Granted Jun 8, 2021·1 cites·17 claims
- 1974US9969701B2Salts and co-crystals of lesinuradCRYSTAL PHARMATECH INC·Filed 2014·Granted May 15, 2018·1 cites·5 claims
- 2073US2024092771A1Crystal form of lanifibranor, preparation method therefor, and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2171US11897848B2Crystalline forms of ozanimod and processes for preparation thereofRECEPTOS LLC·Filed 2021·Granted Feb 13, 2024·0 cites·20 claims
- 2271US11649217B2Crystalline forms of GSK1278863, preparation method and pharmaceutical use thereofGLAXOSMITHKLINE IP NO 2 LTD·Filed 2021·Granted May 16, 2023·0 cites·18 claims
- 2371US9957240B2Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereofCRYSTAL PHARMATECH CO LTD·Filed 2015·Granted May 1, 2018·1 cites·19 claims
- 2470USD999901SFan bladeCHEN MINHUA·Filed 2023·Granted Sep 26, 2023·3 cites·1 claims
- 2569US10377757B2Crystal form of JAK inhibitor and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Aug 13, 2019·1 cites·1 claims
- 2668US10323035B2Co-crystal of a CDK inhibitor and an MEK inhibitor and process of preparation thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Jun 18, 2019·1 cites·19 claims
- 2767USD1038203SMagnifying glass with lightCHEN MINHUA·Filed 2022·Granted Aug 6, 2024·3 cites·1 claims
- 2865USD993384SFanCHEN MINHUA·Filed 2023·Granted Jul 25, 2023·2 cites·1 claims
- 2965US11680050B2Crystalline forms of ozanimod and ozanimod hydrochloride, and processes for preparation thereofRECEPTOS LLC·Filed 2020·Granted Jun 20, 2023·0 cites·7 claims
- 3064US12049463B2Crystalline form of TolebrutinibGENZYME CORP·Filed 2022·Granted Jul 30, 2024·0 cites·4 claims
- 3164US11572365B2Crystal form of upadacitinib, preparation method therefor, and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2022·Granted Feb 7, 2023·0 cites·16 claims
- 3261USD1038202SMagnifying glass with lightCHEN MINHUA·Filed 2022·Granted Aug 6, 2024·2 cites·1 claims
- 3360US2022324808A1Co-crystal of Compound I Dihydrochloride and Preparation Method and Use ThereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3460US2024254236A1Bispecific antibodies and use thereofSHANGHAI NK CELL TECH CO LTD·Filed 2024·Application pending·0 cites
- 3560US2024254194A1Bispecific nk cell agonist, preparation method, and applicationSHANGHAI NK CELL TECH CO LTD·Filed 2024·Application pending·0 cites
- 3659US2024391915A1Crystalline form of tolebrutinib and preparation method thereofPRINCIPIA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3758US11447506B2Crystal forms of crisaborole in free form and preparation method and use thereofANACOR PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·0 cites·18 claims
- 3858US11149004B2Crystalline form of EB-1020, processes for preparation and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2018·Granted Oct 19, 2021·0 cites·10 claims
- 3958US11091494B2Crystal form of acalabrutinib and preparation method and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2018·Granted Aug 17, 2021·0 cites·14 claims
- 4058US10604521B2Crystalline forms of PLX3397 hydrochloride, processes for preparation and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Mar 31, 2020·0 cites·6 claims
- 4158US10138250B2Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of saltCRYSTAL PHARMATECH CO LTD·Filed 2018·Granted Nov 27, 2018·0 cites·8 claims
- 4258US2022267326A1Crystalline form of valbenazine ditosylate, processes for preparation thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 4357US12428402B2Resmetirom crystal, preparation method for same, and uses thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2022·Granted Sep 30, 2025·0 cites·9 claims
- 4457US11773113B2Crystal forms of crisaborole in free form and preparation method and use thereofANACOR PHARMACEUTICALS INC·Filed 2017·Granted Oct 3, 2023·0 cites·14 claims
- 4557US10442800B2Crystal forms of NBI-98854, preparation method and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2017·Granted Oct 15, 2019·0 cites·14 claims
- 4656US11136347B2Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2018·Granted Oct 5, 2021·0 cites·19 claims
- 4756US10815232B2Crystalline forms of viral-protein inhibitor drug VX-787, processes for preparation thereof and use thereofCRYSTAL PHARMACEUTICAL SUZHOU CO LTD·Filed 2018·Granted Oct 27, 2020·0 cites·19 claims
- 4856US10544129B2Crystalline forms of AP26113, and preparation method thereofCRYSTAL PHARMATECH CO LTD·Filed 2017·Granted Jan 28, 2020·0 cites·14 claims
- 4956US10508087B2Crystalline forms of trisodium supramolecular complex comprising valsartan and AHU-377 and methods thereofCHEN MINHUA·Filed 2018·Granted Dec 17, 2019·0 cites·13 claims
- 5056US10266523B2Crystaline forms of N-[6-(cis-2,6-dimethylmorpholine-4-yl)pyridine-3-yl]-2-Methyl-4′-(trifluoromethoxy) [1,1′-biphenyl]-3-Methanamide monophosphate, and process of preparation thereofCRYSTAL PHARMATECH CO LTD·Filed 2016·Granted Apr 23, 2019·0 cites·22 claims
Showing the top 50 of 85 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Minhua Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →